The content provided in this section is part of a third party press release service and does not reflect the editorial views or opinions of IANS. The responsibility for the accuracy, authenticity, and ...
Financial terms of the agreement are not disclosed but include investment participation by Pierre Fabre Laboratories in RedRidge's Series A financing that will be announced separately, as well as ...
DeFi Technologies Increases its Stake in Neuronomics AG to 52.5%: DeFi Technologies acquires a majority stake in Neuronomics AG, a Swiss asset management firm specializing in artificial intelligence ...
"This accolade is yet another affirmation of Fermenta's unwavering commitment to innovation and excellence, towards a sustainable tomorrow," said Fermenta Managing Director, Mr Prashant Nagre. "We ...
Traditional Large Language Models (LLMs) are static. Vurbs represent a revolutionary approach: AI agents that live, learn, and evolve through continuous human interaction. "LLMs are a great starting ...
BARCELONA, Spain, March 7, 2025 /PRNewswire/ -- During MWC Barcelona 2025, at the Huawei Electric Power Summit under the theme of "Thrive with Digital, Accelerate Electric Power Intelligence", Huawei ...
This Women’s Day, Durex is taking a stand with the ‘The Durex Blocker’—a bold, action-driven initiative to combat online harassment by blocking those who engage in it. No warnings. Every time Durex ...
NIAT (NxtWave Institute of Advanced Technologies), a leading institution focused on practical, industry-relevant technology education, is proud to announce the success of its students at Mumbai Tech ...
Merck Foundation, the philanthropic arm of Merck KGaA Germany together with First Ladies of Africa who are also their Ambassadors, Ministries of Health, Education, Communication & Gender, mark ...
CTD402 is a universal CAR-T cell product targeting CD7 derived from healthy donors and intended for the treatment of T-ALL/LBL. It is genetically modified to avoid fratricide, graft-versus-host ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results